{ "schemaVersion": "deck-intelligence.v1", "id": "019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "slug": "66e1021b86be5625", "title": "Global pharma winners – focus and efficiency matter", "subtitle": "Roland Berger", "author": "Roland Berger", "pageCount": 11, "kind": "consulting-deck", "orientation": "portrait", "aspectRatio": 0.707, "document": { "id": "019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "slug": "66e1021b86be5625", "title": "Global pharma winners – focus and efficiency matter", "rawTitle": "Global pharma winners – focus and efficiency matter", "authorId": "RolandBerger", "authorName": "Roland Berger", "authorDisplay": "Roland Berger", "kind": { "slug": "consulting-deck", "label": "Consulting deck" }, "sourceType": { "slug": "strategy_consulting", "label": "Strategy consulting" }, "fileName": "Global-pharma-winners-focus-and-efficiency-matter.pdf", "sourceUrl": "https://www.rolandberger.com/publications/publication_pdf/roland_berger_global_pharma.pdf", "sourceDate": null, "presentationDate": null, "ingestedAt": "2026-04-23 20:51:44+00", "status": "ready", "pageCount": 11, "orientation": "portrait", "aspectRatio": 0.707, "targetCompany": null, "targetTicker": null, "metadata": { "local_root": "/tmp/legacy-images/66e1021b86be5625", "origin_corpus": "consulting" } }, "coverage": { "pageCount": 11, "pagesIndexed": 11, "pagesWithImages": 11, "pagesWithMetadata": 11, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 86, "chartCount": 11, "metricSlides": 0, "toolMatches": 3, "documentToolMatches": 0, "frameworkMatches": 5, "arcMatches": 1, "beatMatches": 5, "loopMatches": 2, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": true, "reviewAvailable": true, "activistThesisAvailable": false, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "evidence": "The document follows a logical structure, starting with an executive summary, key takeaways, diagnosis, case study, and appendix", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 21:09:04.304642+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 3, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 3, "name": "Situation & Context", "beatId": "b92d5c86-de42-4e32-ae1a-b4d3c4ce982a", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Situation & Context", "slug": "consultants-gambit-situation-context", "status": "active", "canonId": "019dd9b8-05ae-741b-992d-65ee83c639b3", "version": 1, "description": null }, "evidence": "The executive summary provides an overview of the situation and context", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 4, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 4, "name": "Problem & Complication", "beatId": "c0ff690b-f9d3-4407-8cfa-8f23f7854e96", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Problem & Complication", "slug": "consultants-gambit-problem-complication", "status": "active", "canonId": "019dd9b8-064a-777f-a374-e9a8c43dedd4", "version": 1, "description": null }, "evidence": "The key takeaways highlight the problems and complications faced by the industry", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 6, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 5, "name": "Evidence & Proof", "beatId": "6c199ca9-8d4d-47cb-b8c0-49f3ad8ac907", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The diagnosis and key takeaways provide evidence and proof of the problems and complications", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 8, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 7, "name": "Solution & Approach", "beatId": "21f7c979-2bb3-47ff-9b60-6ea8a09521aa", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Solution & Approach", "slug": "consultants-gambit-solution-approach", "status": "active", "canonId": "019dd9b8-071c-7161-9184-580fdac7a4f9", "version": 1, "description": null }, "evidence": "The case study and key takeaways provide a solution and approach to addressing the problems and complications", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 9, "name": "Impact & Next Steps", "beatId": "271309e4-eb3d-436f-9b66-ea91610673d4", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Impact & Next Steps", "slug": "consultants-gambit-impact-next-steps", "status": "active", "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655", "version": 1, "description": null }, "evidence": "The main considerations for pharma executives and appendix provide impact and next steps", "position": 4, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null, "categoryName": "Logical Reasoning", "categorySlug": "logical-reasoning" }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 9, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null, "categoryName": "Urgency", "categorySlug": "urgency" }, "matchId": "af7803fc-7fff-46d4-876f-a01233f27297", "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns", "position": 1, "objective": "To highlight the cost of inaction and the importance of efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.564299+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "a84f7ab5-29b2-403e-b3da-24be7f0004fc", "evidence": "The slide features a 2x2 matrix showing Profitless Growers, Winners, Underperformers, and Cash Generators based on Growth and Profit axes.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 21:21:29.739623+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "c1bebe17-bae1-4ce0-afb4-2d10a2167aea", "evidence": "The slide discusses various segments of companies, such as diversified life-sciences-and-beyond companies, blood-plasma therapy companies, consumer health companies, CMOs and CDMOs, digital health companies, traditional biotech companies, generics/biosimilars companies, and new-modality biotech companies, indicating an understanding of the audience.", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 21:21:29.700552+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Chart Selection Guide", "slug": "chart-selection-guide", "status": "active", "bestFor": null, "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae", "version": 1, "bodyDocId": null, "description": "Choosing the right chart type for your data and message", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Designer", "layer": "slide", "agents": [ "Designer" ], "matchId": "247c6088-62de-41bb-a3a7-ee61b3382c50", "evidence": "The slide features various charts, including bar charts and a grouped bar chart, to illustrate key points.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 21:21:29.856321+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "06975d86-dda4-4cd9-9bf6-905d1589c622", "evidence": "Financial performance matrix by product segment [2019-2022] with four quadrants", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "matrix-2x2" }, { "matchId": "f46ed87e-89c6-4ab4-ab5e-85c72c0bd0f7", "evidence": "Winners Analysis diagnostic tool", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "frameworkName": "diagnostic-test" }, { "matchId": "505848c3-55cf-48f4-a931-921648937044", "evidence": "Four distinct characteristics of winning companies presented as a comprehensive set.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "mece-principle" }, { "matchId": "60a38f00-32ee-4910-a9be-d744d64fcda8", "evidence": "The radar chart maps 17 dimensions to assess company performance against 'winners'.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "maturity-model" }, { "matchId": "f183f075-a7cd-4655-bd17-e6196c7dae7f", "evidence": "2x2 grid mapping Growth vs Profit to categorize companies", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 10, "frameworkName": "matrix-2x2" } ], "patterns": [] }, "storymakers": null, "score": { "backend": "claude", "scoredAt": "2026-05-02 13:02:40.202+00", "subScores": { "scqa_arc": 70, "action_titles": 72, "mece_structure": 64, "closing_strength": 52, "evidence_quality": 80, "clarity_of_thesis": 78, "production_quality": 64, "visual_storytelling": 72 }, "totalScore": 69, "coveragePct": 100, "explanations": { "scqa_arc": "Situation (pharma outperforms, slide 3) and Complication (five challenges) are explicit, but the Question is implicit and the Answer is spread thinly across slides 4-9 without a single 'so what' resolution slide.", "action_titles": "Roughly 6 of 9 content slides use insight-bearing titles (e.g. slide 4 'Efficiency measures drive profit'), but slides 7, 9, and 10 default to topic labels ('Case study...', 'Main considerations...', 'Methodical approach...').", "mece_structure": "Sections progress logically (context -> drivers -> segments -> archetypes -> case -> M&A -> framework) but slides 6, 7, 8, and 9 all re-litigate the 'four characteristics', creating overlap rather than crisp MECE buckets.", "closing_strength": "The deck tapers into a diagnostic question list (slide 9) followed by methodology and a corporate disclaimer; there is no recommendation slide, prioritized next steps, or explicit call to action.", "evidence_quality": "Claims are backed by hard data - 125 data points on slide 4's P&L and economic-profit analysis, 10-segment archetype distribution on slide 5, M&A volume and value comparisons on slide 8, and a named biotech case study on slide 7.", "clarity_of_thesis": "Thesis is declarative on the cover ('focus and efficiency matter') and crystallized in the management summary on slide 2 listing the four winner characteristics, with slide 3 framing the five challenges.", "production_quality": "Three slides flagged overcrowded (3, 5, 8) and slide 6 is text-heavy with no chart; action-title discipline is inconsistent (missing on 7, 9, 10) though the four-characteristics framework is reused coherently and footnotes are present.", "visual_storytelling": "Most slides match tool to message (TSR line on slide 3, P&L stacked bar plus scatter on slide 4, segmentation stacked bar on slide 5, radar for the framework on slide 9), but slide 6 carries the central 'four characteristics' synthesis as text-only paragraphs." }, "slidesAnalyzed": 11 }, "review": { "backend": null, "verdict": "Solid analytical thought-leadership deck with strong action titles in the middle, but it ends in open questions instead of a recommendation — useful as a teaching example for evidence-led titles, not for closing structure.", "reviewedAt": "2026-04-25 08:48:52+00", "slidesSeen": 11, "suggestions": [ "Replace p.9 with an explicit recommendation slide ('Pharma executives should prioritize X, Y, Z') and move the open questions to a follow-up workshop slide", "Rewrite p.7 title to state what the case study proves, e.g. 'Novo Nordisk illustrates how the four pillars compound into TSR outperformance'", "Insert a complication slide between p.3 and p.4 framing why traditional pharma playbooks now fail, before pivoting to what winners do differently" ], "closingScore": 55, "openingScore": 65, "topStrengths": [ "Action titles on p.4, p.5, p.8 state findings rather than topics ('Efficiency measures drive profit', 'Winners are more active in M&A')", "TOC callout on p.2 previews the four-pillar thesis, giving the reader a frame before the analysis lands", "Analytical middle (p.4-8) consistently pairs a numeric callout with an insight title — solid evidence-led build" ], "topWeaknesses": [ "Closing slide p.9 is a question list, not a recommendation — fails the 'so what / now what' test", "p.7 case-study title is a topic label ('leadership, strategy, financial position and execution') rather than what the case proves", "No explicit complication slide — jumps from cover to 'five challenges' without sharpening why this matters now", "No section dividers; the four-pillar frame is implicit, so the MECE structure is hard to see at a glance" ], "narrativeScore": 68, "pillarCritique": "There are no explicit section dividers; the deck is a linear sequence rather than MECE pillars, though the four winner characteristics (leadership, strategy, finance, execution) are reused as an implicit organizing frame from p.2 onward.", "closingCritique": "The closing slide (p.9 'Main considerations for pharma executives') is a list of questions rather than a recommendation or call to action — it punts the decision back to the reader. There is no 'what to do Monday morning' slide before the appendix on p.10.", "openingCritique": "The TOC on p.2 leaks the thesis via callout ('winners share four characteristics...'), which is a decent hook, but p.1 is a bare cover and p.3 jumps to 'five key challenges' without first sharpening the stakes for the reader. The thesis is visible by p.2-3 but never lead-with-the-answer crisp.", "extractionSeconds": 43.23486, "narrativeCritique": "The deck follows a partial S→C→A→R arc: context (p.3), analysis (p.4-8), and a soft resolution via executive questions (p.9), but the 'complication' is thin and the resolution stops at questions rather than recommendations. The TOC callout previews the four-pillar thesis early, which helps coherence.", "titleQualityScore": 72, "titleQualityCritique": "Most titles are declarative and insight-bearing — 'Efficiency measures drive profit' (p.4), 'Three segments have highest share of winners' (p.5), 'Winners are more active in M&A' (p.8) — but a few default to topic labels like 'Case study – leadership, strategy, financial position and execution' (p.7) and 'Main considerations for pharma executives' (p.9)." }, "activistThesis": null, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "setup", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/MocztuaYRxdOFFtKjq6j_hB00aTnoe4ZGPEwgLjs3nI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82NmUxMDIxYjg2YmU1NjI1L3AwMDEuanBn", "rawType": "cover", "block": null, "metadata": { "slideType": "cover", "slideTypeCanon": { "name": "Cover", "slug": "cover", "status": "active", "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "balanced", "densityScore": 28, "componentCount": 6, "textChars": 119, "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text", "photo", "logo_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:03:57.821+00", "seconds": 2.387, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/1", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-1", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.9, "x": 0.05, "y": 0.015 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:57.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "23a91d8c-b755-494b-9f69-cc07570bb50a", "parentComponentId": null }, { "bbox": { "h": 0.015, "w": 0.15, "x": 0.303, "y": 0.205 }, "kind": "paragraph", "text": "MUNICH / GERMANY", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:57.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "26aa4f34-8c43-466c-9441-4cc1c5e7afa2", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.9, "x": 0.05, "y": 0.74 }, "kind": "title", "text": "Global pharma winners – focus and efficiency matter", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:57.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "534243fa-5394-41b4-a3b5-3d8bb1707e83", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.25, "x": 0.303, "y": 0.035 }, "kind": "title", "text": "Report", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:57.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "95d4b59a-8d96-4ff1-b6c6-0bf58e089e53", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.5, "x": 0.05, "y": 0.835 }, "kind": "title", "text": "HOW TO SUCCEED IN UNCERTAIN TIMES", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:57.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5d427640-d200-40cf-bf3d-336f29d3ccc3", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.2, "x": 0.303, "y": 0.105 }, "kind": "title", "text": "Roland Berger", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:57.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "966d4380-814a-4ace-8989-5cec6e26f58f", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/CVDecHKWynVSeX_CR7-eQdmiMpfqF17UXEttUpxCT0o/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82NmUxMDIxYjg2YmU1NjI1L3AwMDEuanBn", "imagePathAlt": "https://imgproxy.kitesheet.com/MtAOPLKtfdJL5-wBZhTs_TqkGuLSNkfJRjyuR2U1_FI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82NmUxMDIxYjg2YmU1NjI1L3AwMDEucG5n", "thumbSrcAlt": "https://imgproxy.kitesheet.com/d2it-6ky9RbsrmH7mgRm80Ye12gUDG6ZyRTBY1cSqc8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82NmUxMDIxYjg2YmU1NjI1L3AwMDEucG5n" }, { "page": 2, "type": "setup", "title": "This slide appears to be a spread (pages 2 and 3) presented as a single image.", "function": "front_matter", "rawType": "table_of_contents", "block": null, "metadata": { "slideType": "table_of_contents", "slideTypeCanon": { "name": "Table of contents", "slug": "table_of_contents", "status": "active", "canonId": "019de52d-0643-721b-9b85-69676bb85cf8", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "dense", "densityScore": 63, "componentCount": 6, "textChars": 945, "nDataPoints": 12, "notes": "This slide appears to be a spread (pages 2 and 3) presented as a single image.", "elementsJson": [ "numbered_list", "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:03:58.448+00", "seconds": 2.838, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/2", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-2", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Pharma winners share four characteristics: business leadership, strategic coherence, proven ability to execute, and appropriate size and financial position.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:27+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16a-0d318211bcdb", "parentComponentId": null }, { "bbox": { "h": 0.34, "w": 0.29, "x": 0.609, "y": 0.188 }, "kind": "list", "text": "1/ A GROWTH CHAMPION FACES FIVE KEY CHALLENGES 4\n2/ EFFICIENCY GAINS DRIVE STRONG INVESTOR RETURNS 5\n3/ WINNERS CLEARLY AND CONSISTENTLY OUTPERFORM 7\n4/ WINNERS IN DIFFERENT SEGMENTS SHARE KEY STRENGTHS 11\n5/ MAIN CONSIDERATIONS FOR PHARMA EXECUTIVES 16\nAPPENDIX 17", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Numbered list", "slug": "numbered", "status": "active", "canonId": "019de52c-fcc0-7718-a284-a4250c805df2", "version": 1, "description": null }, "framework": null }, "subkind": "numbered", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.448+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7a9db865-7eff-40b6-ab4c-99854d0452ee", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.39, "x": 0.109, "y": 0.257 }, "kind": "paragraph", "text": "The Roland Berger Global Pharma Study 2023 analyzes an industry that has traditionally outperformed leading stock-market indices. Pharma companies recently extended this run by transforming into leaner omnichannel organizations...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.448+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "009a0c82-2429-45ff-b531-444fcffda62a", "parentComponentId": null }, { "bbox": { "h": 0.31, "w": 0.39, "x": 0.609, "y": 0.615 }, "kind": "paragraph", "text": "representing on average only 22% of revenues compared with 30% for underperformers. Winners also have lower cost of goods sold (COGS), with on average only 32% compared with 40% for underperformers. Lastly, our analysis shows that size and financial position matter...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.448+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "46043478-2b99-42a7-8f44-7a6f68881234", "parentComponentId": null }, { "bbox": { "h": 0.026, "w": 0.082, "x": 0.609, "y": 0.094 }, "kind": "title", "text": "CONTENTS", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.448+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3b6138ae-f3df-44e7-9a4b-4507b4118882", "parentComponentId": null }, { "bbox": { "h": 0.026, "w": 0.205, "x": 0.109, "y": 0.094 }, "kind": "title", "text": "MANAGEMENT SUMMARY", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.448+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5f9d09de-c687-4085-8067-61d46770c407", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 3, "type": "setup", "title": "The slide is a two-column layout summarizing industry context and financial performance.", "function": "summarize", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 79, "componentCount": 10, "textChars": 736, "nDataPoints": 3, "notes": "The slide is a two-column layout summarizing industry context and financial performance.", "elementsJson": [ "paragraph", "numbered_list", "line_chart", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:04:03.622+00", "seconds": 7.998, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/3", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-3", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Pharma TSR consistently outperformed global stock markets [2018-2022]", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:28+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-4b2fd334d61d", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.4, "x": 0.53, "y": 0.56 }, "kind": "chart", "text": "Pharma TSR consistently outperformed global stock markets [2018-2022]", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7a91a493-89d7-44d9-a4d6-b6ae455702da", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.4, "x": 0.05, "y": 0.45 }, "kind": "list", "text": "1. Small molecule drug companies... 10. Diversified life-sciences-and-beyond companies...", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Numbered list", "slug": "numbered", "status": "active", "canonId": "019de52c-fcc0-7718-a284-a4250c805df2", "version": 1, "description": null }, "framework": null }, "subkind": "numbered", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e7c2b869-5518-47ed-b814-69c7d9c6388b", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Total shareholder return (TSR): 23.8%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:28+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-4c08d3fec50d", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.4, "x": 0.53, "y": 0.13 }, "kind": "paragraph", "text": "The pharma industry has traditionally enjoyed higher profit margins than other industries, which have translated into above-average TSR.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "49b1b46a-a4dc-4b70-9659-69306e3f0fb6", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.4, "x": 0.05, "y": 0.13 }, "kind": "paragraph", "text": "Pharmaceutical (\"pharma\") companies research, develop, produce and/or market drugs to cure diseases, alleviate symptoms and increasingly also to prevent sickness.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8fb24838-4c92-420e-88d6-0fe801bcd4d3", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.2, "x": 0.53, "y": 0.88 }, "kind": "source-note", "text": "Source: Roland Berger, Capital IQ", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b1865206-acca-49c5-a698-d871a9cde40f", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.4, "x": 0.53, "y": 0.53 }, "kind": "title", "text": "A / Strong profitability leads to high returns", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "939044c2-7f8c-4273-9a46-1fb88665e3d7", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.4, "x": 0.53, "y": 0.09 }, "kind": "title", "text": "2/ Efficiency gains drive strong investor returns", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c3e09799-7a74-4433-8c7d-b2aa4527b347", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.4, "x": 0.05, "y": 0.09 }, "kind": "title", "text": "1/ A growth champion faces five key challenges", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:03.622+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ee62881e-e5a2-4f34-b9b0-389b428ab2ff", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 3, "name": "Situation & Context", "beatId": "b92d5c86-de42-4e32-ae1a-b4d3c4ce982a", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Situation & Context", "slug": "consultants-gambit-situation-context", "status": "active", "canonId": "019dd9b8-05ae-741b-992d-65ee83c639b3", "version": 1, "description": null }, "evidence": "The executive summary provides an overview of the situation and context", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 4, "type": "resolution", "title": "The slide contains two distinct sections (B and C) summarizing different aspects of pharma industry performance.", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 77, "componentCount": 9, "textChars": 619, "nDataPoints": 35, "notes": "The slide contains two distinct sections (B and C) summarizing different aspects of pharma industry performance.", "elementsJson": [ "bar_chart_100pct", "scatter_plot", "paragraph", "big_number" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:03:59.295+00", "seconds": 3.593, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/4", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-4", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Winners clearly and consistently outperform.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:28+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-29bc9b6f48a9", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.42, "x": 0.03, "y": 0.16 }, "kind": "chart", "text": "P&L developments from 2008 to 2022", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked bar chart (100%)", "slug": "bar-stacked-100pct", "status": "active", "canonId": "019de52c-ff14-71b8-8d88-860f8d7da84b", "version": 1, "description": null }, "framework": null }, "subkind": "bar-stacked-100pct", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "684caef6-ef8d-474c-ac5d-2c9a38337f68", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.42, "x": 0.53, "y": 0.5 }, "kind": "chart", "text": "Financial performance matrix by product segment [2019-2022]", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Scatter plot", "slug": "scatter", "status": "active", "canonId": "019de52d-007d-72ec-8689-c79fb78e21a2", "version": 1, "description": null }, "framework": null }, "subkind": "scatter", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "34f6e59e-edaf-44c6-b5da-e70d03d8afeb", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Total Average Shareholder Return: 22%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:28+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-2cac2e05c10f", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.42, "x": 0.53, "y": 0.22 }, "kind": "paragraph", "text": "Our analysis of how individual companies are creating value for shareholders identified a wide disparity within the pharma industry.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d8971249-23bb-4c60-99c6-dde180d9460a", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.42, "x": 0.03, "y": 0.58 }, "kind": "paragraph", "text": "For example, companies developed lean omnichannel marketing and sales organizations and cut sales forces as face-to-face contact with healthcare professionals declined during the pandemic.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e2e538f1-5aed-4d5d-b2e9-6f80649040db", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.35, "x": 0.53, "y": 0.43 }, "kind": "title", "text": "C / Winners operate in almost every segment", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2e082b84-46dd-41e0-9360-bc3b8b3d27c2", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.35, "x": 0.53, "y": 0.18 }, "kind": "title", "text": "3/ Winners clearly and consistently outperform", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "55f8c638-8c64-47ad-9488-01f6122d730b", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.3, "x": 0.03, "y": 0.09 }, "kind": "title", "text": "B / Efficiency measures drive profit", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c0a31009-4384-49ab-b051-bbaa784bfaa5", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "06975d86-dda4-4cd9-9bf6-905d1589c622", "evidence": "Financial performance matrix by product segment [2019-2022] with four quadrants", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:03:59.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "matrix-2x2" } ], "arcBeats": [ { "to": 4, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 4, "name": "Problem & Complication", "beatId": "c0ff690b-f9d3-4407-8cfa-8f23f7854e96", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Problem & Complication", "slug": "consultants-gambit-problem-complication", "status": "active", "canonId": "019dd9b8-064a-777f-a374-e9a8c43dedd4", "version": 1, "description": null }, "evidence": "The key takeaways highlight the problems and complications faced by the industry", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 9, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "af7803fc-7fff-46d4-876f-a01233f27297", "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns", "position": 1, "objective": "To highlight the cost of inaction and the importance of efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.564299+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 5, "type": "analysis", "title": "The slide uses a stacked bar chart to segment companies into four performance archetypes across various industry sub-sectors.", "function": "diagnose", "rawType": "diagnosis", "block": null, "metadata": { "slideType": "diagnosis", "slideTypeCanon": { "name": "Diagnosis", "slug": "diagnosis", "status": "active", "canonId": "019de52d-0cd7-7212-898f-0464041ff8d8", "version": 1, "description": null }, "function": "diagnose", "functionCanon": { "name": "Diagnose", "slug": "diagnose", "status": "active", "canonId": "019de52d-1657-7223-acc5-7437d878c850", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 79, "componentCount": 9, "textChars": 668, "nDataPoints": 40, "notes": "The slide uses a stacked bar chart to segment companies into four performance archetypes across various industry sub-sectors.", "elementsJson": [ "headline_text", "bar_chart_stacked", "data_table", "paragraph", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:03:58.67+00", "seconds": 2.962, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/5", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-5", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Blood plasma, CMO/CDMOs and traditional biotechs stand out 2019–2022.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:29+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-abcc8818abdd", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.43, "x": 0.535, "y": 0.15 }, "kind": "chart", "text": "Stacked bar chart showing performance archetypes by segment", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked bar chart (100%)", "slug": "bar-stacked-100pct", "status": "active", "canonId": "019de52c-ff14-71b8-8d88-860f8d7da84b", "version": 1, "description": null }, "framework": null }, "subkind": "bar-stacked-100pct", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bce8d204-c927-41f4-b5de-f91ab2e18e68", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.39, "x": 0.1, "y": 0.56 }, "kind": "list", "text": "1. Winners, 2. Value generators, 3. Profitless growers, 4. Underperformers", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Numbered list", "slug": "numbered", "status": "active", "canonId": "019de52c-fcc0-7718-a284-a4250c805df2", "version": 1, "description": null }, "framework": null }, "subkind": "numbered", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "61cc7209-f19d-4691-b650-5007988d0d7d", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Share of winners: 67%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:29+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-ae5ade006b27", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.35, "x": 0.608, "y": 0.58 }, "kind": "paragraph", "text": "While small molecule drug companies and consumer-health companies on average recorded the lowest share of winners between 2019 and 2022...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4236c319-f248-4f92-ba2f-64a3a9d53967", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.39, "x": 0.1, "y": 0.095 }, "kind": "paragraph", "text": "Our Winners Analysis is a diagnostic tool for understanding a company's past performance as a blueprint for future strategy.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9e0865d1-9415-46e1-addc-f5d638667ff3", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.2, "x": 0.535, "y": 0.5 }, "kind": "source-note", "text": "*) Excluding one extreme outlier. Source: Roland Berger, Capital IQ", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f377ca16-5b87-49bd-9934-1912c5391ec9", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.4, "x": 0.535, "y": 0.115 }, "kind": "title", "text": "Blood plasma, CMO/CDMOs and traditional biotechs stand out 2019–2022", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "10121120-1d19-4ad1-8966-2c38ced2c185", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.4, "x": 0.535, "y": 0.095 }, "kind": "title", "text": "D / Three segments have highest share of winners", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ecb57bd6-ce0c-4880-bed6-6dc080d5f1ae", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "f46ed87e-89c6-4ab4-ab5e-85c72c0bd0f7", "evidence": "Winners Analysis diagnostic tool", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 19:03:58.67+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "frameworkName": "diagnostic-test" } ], "arcBeats": [ { "to": 6, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 5, "name": "Evidence & Proof", "beatId": "6c199ca9-8d4d-47cb-b8c0-49f3ad8ac907", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The diagnosis and key takeaways provide evidence and proof of the problems and complications", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 9, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "af7803fc-7fff-46d4-876f-a01233f27297", "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns", "position": 1, "objective": "To highlight the cost of inaction and the importance of efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.564299+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 6, "type": "resolution", "title": "This slide appears to be a composite of two pages (10 and 11) from a Roland Berger report on Global Pharma.", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 88, "componentCount": 13, "textChars": 2291, "nDataPoints": 0, "notes": "This slide appears to be a composite of two pages (10 and 11) from a Roland Berger report on Global Pharma.", "elementsJson": [ "paragraph", "headline_text" ], "confidence": 0.9, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:04:00.086+00", "seconds": 4.303, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/6", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-6", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "The success of all winning pharma companies is founded on: 1) business leadership, 2) strategic coherence, 3) financial position and 4) a proven ability to execute plans.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:32+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58e-76cb-be48-b4dcf5c66fd6", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.608, "y": 0.613 }, "kind": "paragraph", "text": "Diversified life-sciences-and-beyond companies are active in life sciences and other areas beyond such as chemicals. Within this segment, companies with fast-moving consumer goods (FMCG) operations in their portfolio have been able to outperform.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4e595d70-6f16-48db-a60a-9b7cf4ddf1a3", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.608, "y": 0.473 }, "kind": "paragraph", "text": "Diversified life-sciences-focused companies have the most even spread of winners, cash generators, profitless growers and underperformers.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4ec65044-c6c5-4cf1-895d-62b7cb4da12c", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.39, "x": 0.109, "y": 0.683 }, "kind": "paragraph", "text": "Consumer health companies have the highest share of value generators, even as revenues grow below the industry average. This segment has traditionally been one of lower risks and lower returns.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4f656c6c-c8dd-4152-8a54-5352b763dcde", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.608, "y": 0.098 }, "kind": "paragraph", "text": "While some digital health companies are growing profitably at rates above the industry average, more than two-thirds of the companies in this segment have limited or no profitability.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5cb0d5df-484e-4a0f-a75b-d90922faa8b6", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.608, "y": 0.768 }, "kind": "paragraph", "text": "Our analysis identified four characteristics that winners have in common: 1) business leadership, 2) strategic coherence, 3) financial position and 4) a proven ability to execute plans.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6618fe83-8e33-443d-b0ae-bc4e3ff3f964", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.109, "y": 0.188 }, "kind": "paragraph", "text": "Traditional biotech companies count the third-highest share of winners. But overall the segment of companies not focusing on new biotech modalities offers a mixed picture.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "70fa605a-0857-47ba-aad0-41acb93741d4", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.608, "y": 0.348 }, "kind": "paragraph", "text": "CMOs and CDMOs have the second-largest share of winners of all segments. A wave of consolidation and increased strategic focus has improved utilization rates and efficiency in production.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7d1c9efe-b581-4f7e-b5a8-059097bca5fd", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.608, "y": 0.223 }, "kind": "paragraph", "text": "The vast majority of generics/biosimilars companies are value generators or underperformers, indicating below-average revenue growth usually translates into negative TSR.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "89ebb882-978c-48b2-a3e9-786855c1e949", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.109, "y": 0.098 }, "kind": "paragraph", "text": "The effects of the COVID-19 pandemic aside, this segment faces innovation challenges. Companies have harvested the low-hanging fruits and can now only target indications with much smaller patient populations.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ca014892-a9ad-4b62-abbd-57208d6eec0d", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.109, "y": 0.558 }, "kind": "paragraph", "text": "Interestingly, blood-plasma therapy companies have the highest share of winners. This highly focused segment has profited from faster market growth as blood disorders such as malignancies and leukemia have gained in prevalence.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d0dd163c-66e8-4847-a00c-019bef5a8e8a", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.39, "x": 0.109, "y": 0.323 }, "kind": "paragraph", "text": "On the other hand, new-modality biotech companies, including cell and gene therapies (CGT), have not been very profitable, even as revenues have grown considerably.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fa50a8d9-be1d-4b16-b2fa-613051b6f651", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.33, "x": 0.608, "y": 0.718 }, "kind": "title", "text": "Winners in different segments share key strengths", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.086+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3ae208ca-5997-44c5-b7a1-3f7253bbfbd3", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "a84f7ab5-29b2-403e-b3da-24be7f0004fc", "evidence": "The slide features a 2x2 matrix showing Profitless Growers, Winners, Underperformers, and Cash Generators based on Growth and Profit axes.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 21:21:29.739623+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "c1bebe17-bae1-4ce0-afb4-2d10a2167aea", "evidence": "The slide discusses various segments of companies, such as diversified life-sciences-and-beyond companies, blood-plasma therapy companies, consumer health companies, CMOs and CDMOs, digital health companies, traditional biotech companies, generics/biosimilars companies, and new-modality biotech companies, indicating an understanding of the audience.", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 21:21:29.700552+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 6, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 5, "name": "Evidence & Proof", "beatId": "6c199ca9-8d4d-47cb-b8c0-49f3ad8ac907", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The diagnosis and key takeaways provide evidence and proof of the problems and complications", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 9, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "af7803fc-7fff-46d4-876f-a01233f27297", "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns", "position": 1, "objective": "To highlight the cost of inaction and the importance of efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.564299+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 7, "type": "evidence", "title": "The slide combines a framework of four winning characteristics with a specific company case study and supporting data charts on disease focus and ESG performanc", "function": "illustrate_case", "rawType": "case_study", "block": null, "metadata": { "slideType": "case_study", "slideTypeCanon": { "name": "Case study", "slug": "case_study", "status": "active", "canonId": "019de52d-0b95-7344-8090-926f3b8e92c8", "version": 1, "description": null }, "function": "illustrate_case", "functionCanon": { "name": "Illustrate case", "slug": "illustrate_case", "status": "active", "canonId": "019de52d-13b4-772c-bb73-1873612a7463", "version": 1, "description": null }, "density": "dense", "densityScore": 66, "componentCount": 8, "textChars": 499, "nDataPoints": 10, "notes": "The slide combines a framework of four winning characteristics with a specific company case study and supporting data charts on disease focus and ESG performance.", "elementsJson": [ "icon_grid", "paragraph", "bar_chart_stacked", "bar_chart_vertical" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:04:01.929+00", "seconds": 5.953, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/7", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-7", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Winning companies share four characteristics measured by key performance indicators.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:30+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16c-2447ebeedfc2", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.2, "x": 0.52, "y": 0.062 }, "kind": "chart", "text": "Winners often focus on specific disease areas", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked bar chart", "slug": "bar-stacked", "status": "active", "canonId": "019de52c-feec-74bf-9028-15b74f84f0a7", "version": 1, "description": null }, "framework": null }, "subkind": "bar-stacked", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "10669427-36d9-4e0c-9965-59633cd6415b", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.2, "x": 0.76, "y": 0.062 }, "kind": "chart", "text": "Winners score better in ESG", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "569df73a-e999-4118-a41e-14329f3ae28a", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.45, "x": 0.05, "y": 0.1 }, "kind": "framework", "text": "Winning companies share four characteristics", "attrs": null, "canon": { "kind": { "name": "Framework", "slug": "framework", "status": "active", "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa", "version": 1, "description": "Named conceptual framework instance." }, "tool": null, "subkind": { "name": "Framework instance", "slug": "instance", "status": "active", "canonId": "019de52d-05a2-72af-be0b-7edc60708a03", "version": 1, "description": null }, "framework": null }, "subkind": "instance", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5ee20363-d654-461b-ad04-d1e39a3e3c1a", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "EBITDA margin: 40%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:30+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16c-2a06d96e4900", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.45, "x": 0.52, "y": 0.1 }, "kind": "paragraph", "text": "Beyond achieving its growth targets, this player is also able to maintain a strong financial position...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d0debce9-58de-4e1d-a839-74040c7d59ba", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.4, "x": 0.05, "y": 0.62 }, "kind": "paragraph", "text": "We analyzed a leading traditional biotech company highly focused on metabolic diseases, especially diabetes...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d8cc01c3-994c-4faa-9dc6-e918ba7c3ada", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.4, "x": 0.05, "y": 0.46 }, "kind": "title", "text": "Case study – leadership, strategy, financial position and execution", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6524a228-a5ee-4038-8d31-0a5517dae0e9", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "505848c3-55cf-48f4-a931-921648937044", "evidence": "Four distinct characteristics of winning companies presented as a comprehensive set.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:04:01.929+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "mece-principle" } ], "arcBeats": [ { "to": 8, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 7, "name": "Solution & Approach", "beatId": "21f7c979-2bb3-47ff-9b60-6ea8a09521aa", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Solution & Approach", "slug": "consultants-gambit-solution-approach", "status": "active", "canonId": "019dd9b8-071c-7161-9184-580fdac7a4f9", "version": 1, "description": null }, "evidence": "The case study and key takeaways provide a solution and approach to addressing the problems and complications", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 9, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "af7803fc-7fff-46d4-876f-a01233f27297", "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns", "position": 1, "objective": "To highlight the cost of inaction and the importance of efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.564299+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 8, "type": "resolution", "title": "This slide appears to be a composite of two pages (14 and 15) from a Roland Berger deck. It contains multiple charts and text blocks summarizing findings.", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "dense", "densityScore": 56, "componentCount": 7, "textChars": 416, "nDataPoints": 14, "notes": "This slide appears to be a composite of two pages (14 and 15) from a Roland Berger deck. It contains multiple charts and text blocks summarizing findings.", "elementsJson": [ "bar_chart_vertical", "bar_chart_grouped", "paragraph" ], "confidence": 0.9, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:04:00.821+00", "seconds": 4.696, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/8", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-8", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Winners pursue active portfolio management, with a higher average number and value of M&A transactions than underperformers.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:30+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-ec443c2d1d3a", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.2, "x": 0.25, "y": 0.065 }, "kind": "chart", "text": "COGS and SG&A share comparison", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Grouped bar chart", "slug": "bar-grouped", "status": "active", "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1", "version": 1, "description": null }, "framework": null }, "subkind": "bar-grouped", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "02c8ff3d-ae37-4620-a9e0-cb60c916e74e", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.15, "x": 0.05, "y": 0.15 }, "kind": "chart", "text": "M&A activity comparison", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "727c67b7-72c9-4a6a-84a3-9a2c830b32a7", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.2, "x": 0.55, "y": 0.055 }, "kind": "chart", "text": "Market cap and Debt-to-EBITDA comparison", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "951eb900-b353-47c6-aa66-eccea93c0d3f", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.15, "x": 0.75, "y": 0.035 }, "kind": "chart", "text": "Global presence (number of affiliates)", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9b42482a-1a87-43ca-9948-6c59054a888a", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "M&A deal value: 1,950", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:30+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58d-7080-a16b-f0ae48dbf156", "parentComponentId": null }, { "bbox": { "h": 0.8, "w": 0.7, "x": 0.25, "y": 0.1 }, "kind": "paragraph", "text": "Winners are more active in M&A, allocate resources more efficiently, have better financial positions, and maintain a larger global presence.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.821+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c45d2b9f-f859-407f-9ffa-d16edd3cd85a", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Chart Selection Guide", "slug": "chart-selection-guide", "status": "active", "bestFor": null, "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae", "version": 1, "bodyDocId": null, "description": "Choosing the right chart type for your data and message", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Designer", "layer": "slide", "agents": [ "Designer" ], "matchId": "247c6088-62de-41bb-a3a7-ee61b3382c50", "evidence": "The slide features various charts, including bar charts and a grouped bar chart, to illustrate key points.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 21:21:29.856321+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 8, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 7, "name": "Solution & Approach", "beatId": "21f7c979-2bb3-47ff-9b60-6ea8a09521aa", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Solution & Approach", "slug": "consultants-gambit-solution-approach", "status": "active", "canonId": "019dd9b8-071c-7161-9184-580fdac7a4f9", "version": 1, "description": null }, "evidence": "The case study and key takeaways provide a solution and approach to addressing the problems and complications", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 9, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "af7803fc-7fff-46d4-876f-a01233f27297", "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns", "position": 1, "objective": "To highlight the cost of inaction and the importance of efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.564299+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 9, "type": "analysis", "title": "The slide uses a radar chart to visualize a maturity or performance model for pharma companies.", "function": "diagnose", "rawType": "diagnosis", "block": null, "metadata": { "slideType": "diagnosis", "slideTypeCanon": { "name": "Diagnosis", "slug": "diagnosis", "status": "active", "canonId": "019de52d-0cd7-7212-898f-0464041ff8d8", "version": 1, "description": null }, "function": "diagnose", "functionCanon": { "name": "Diagnose", "slug": "diagnose", "status": "active", "canonId": "019de52d-1657-7223-acc5-7437d878c850", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 81, "componentCount": 8, "textChars": 1167, "nDataPoints": 17, "notes": "The slide uses a radar chart to visualize a maturity or performance model for pharma companies.", "elementsJson": [ "headline_text", "paragraph", "radar_chart", "bullet_list" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:04:06.23+00", "seconds": 10.069, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/9", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-9", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Our analysis shows that pharma company executives now need to consider the following key questions - and to find solutions to overcoming any potentially identified gaps.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:30+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58e-76cb-be47-b3cb38e00c98", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.38, "x": 0.11, "y": 0.35 }, "kind": "chart", "text": "Radar chart showing 17 dimensions across 4 pillars: Business Leadership, Strategic Coherence, Proven Ability to Execute, Size and Financial Position.", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Radar chart", "slug": "radar", "status": "active", "canonId": "019de52d-00f5-74e6-82d0-74c065f6f4a9", "version": 1, "description": null }, "framework": null }, "subkind": "radar", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "705a231c-a81c-4436-b9b0-a3a87e406f5f", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.38, "x": 0.11, "y": 0.35 }, "kind": "framework", "text": "Assessment Grid", "attrs": null, "canon": { "kind": { "name": "Framework", "slug": "framework", "status": "active", "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa", "version": 1, "description": "Named conceptual framework instance." }, "tool": null, "subkind": { "name": "Framework instance", "slug": "instance", "status": "active", "canonId": "019de52d-05a2-72af-be0b-7edc60708a03", "version": 1, "description": null }, "framework": null }, "subkind": "instance", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c023788-f154-4dfd-a0e8-31adf4ce8aed", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.35, "x": 0.11, "y": 0.87 }, "kind": "legend", "text": "Largest difference between winners & underperformers; Smallest difference between winners & underperformers", "attrs": null, "canon": { "kind": { "name": "Legend", "slug": "legend", "status": "active", "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c", "version": 1, "description": "Color/symbol decoder placed adjacent to a chart or diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "11346d4a-ba4c-4fb5-85be-694ee33a5a02", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.35, "x": 0.58, "y": 0.26 }, "kind": "list", "text": "Overall: where does my company stand today? Business leadership: is my company a top three player? Strategic coherence: does it display strategic coherence? Proven ability to execute: is it prioritizing resources? Size and financial position: does it have the strength?", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d0796ee0-b898-4bb1-a16f-862b43883fd0", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.38, "x": 0.11, "y": 0.15 }, "kind": "paragraph", "text": "Pharma companies should concentrate on the four characteristics that winners have in common. Roland Berger's assessment grid is a powerful tool with which companies can benchmark their business.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c1be6d7b-2454-410c-b34c-b1521afa2d0e", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.35, "x": 0.58, "y": 0.18 }, "kind": "paragraph", "text": "ESSENTIAL QUESTIONS PHARMA EXECUTIVES NEED TO ANSWER. Our analysis shows that pharma company executives now need to consider the following key questions - and to find solutions to overcoming any potentially identified gaps:", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fe8bf54f-fc38-4612-b4c4-2d937da69a2e", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.3, "x": 0.11, "y": 0.09 }, "kind": "title", "text": "Main considerations for pharma executives", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5fe4d49b-5ed9-456a-8413-fe116739875e", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "60a38f00-32ee-4910-a9be-d744d64fcda8", "evidence": "The radar chart maps 17 dimensions to assess company performance against 'winners'.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:04:06.23+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "maturity-model" } ], "arcBeats": [ { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 9, "name": "Impact & Next Steps", "beatId": "271309e4-eb3d-436f-9b66-ea91610673d4", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Impact & Next Steps", "slug": "consultants-gambit-impact-next-steps", "status": "active", "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655", "version": 1, "description": null }, "evidence": "The main considerations for pharma executives and appendix provide impact and next steps", "position": 4, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 9, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "af7803fc-7fff-46d4-876f-a01233f27297", "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns", "position": 1, "objective": "To highlight the cost of inaction and the importance of efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.564299+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 10, "type": "setup", "title": "Includes a list of authors and contributors on the right side.", "function": "present_framework", "rawType": "appendix_methodology", "block": null, "metadata": { "slideType": "appendix_methodology", "slideTypeCanon": { "name": "Appendix methodology", "slug": "appendix_methodology", "status": "active", "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 76, "componentCount": 8, "textChars": 1711, "nDataPoints": 0, "notes": "Includes a list of authors and contributors on the right side.", "elementsJson": [ "bullet_list", "matrix_2x2", "process_diagram", "other" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:04:00.804+00", "seconds": 4.182, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/10", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-10", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": { "h": 0.22, "w": 0.46, "x": 0.04, "y": 0.68 }, "kind": "diagram", "text": "Risk-adjusted profitability formula: ROIC (Return on Invested Capital) vs WACC (Weighted Average Cost of Capital).", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5e3d7f40-b422-4f3c-a87d-aa8604090b67", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.43, "x": 0.53, "y": 0.89 }, "kind": "disclaimer", "text": "This publication has been prepared for general guidance only. The reader should not act according to any information provided in this information without receiving specific professional advice. Roland Berger GmbH shall not be liable for any damages resulting from any use of the information contained in the publication. © 2023 ROLAND BERGER GMBH. ALL RIGHTS RESERVED.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2803f8f7-0b1e-4acb-ac45-8febd229143b", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.46, "x": 0.04, "y": 0.42 }, "kind": "framework", "text": "2x2 matrix showing Profitless Growers, Winners, Underperformers, and Cash Generators based on Growth and Profit axes.", "attrs": null, "canon": { "kind": { "name": "Framework", "slug": "framework", "status": "active", "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa", "version": 1, "description": "Named conceptual framework instance." }, "tool": null, "subkind": { "name": "Framework instance", "slug": "instance", "status": "active", "canonId": "019de52d-05a2-72af-be0b-7edc60708a03", "version": 1, "description": null }, "framework": null }, "subkind": "instance", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a0124d69-7264-41ba-b094-f5c3b3562a81", "parentComponentId": null }, { "bbox": null, "kind": "framework", "text": "2x2 Matrix", "attrs": null, "canon": { "kind": { "name": "Framework", "slug": "framework", "status": "active", "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa", "version": 1, "description": "Named conceptual framework instance." }, "tool": { "name": "Structuring frame", "slug": "structuring-frame", "status": "active", "bestFor": null, "canonId": "019dd9e1-48ff-708d-8103-a8464743e560", "version": 1, "bodyDocId": null, "description": "A named scaffold for organising content (SCQA, situation-action-result, etc.).", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:53:30+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-e58e-76cb-be47-c871879b5425", "parentComponentId": null }, { "bbox": { "h": 0.78, "w": 0.43, "x": 0.53, "y": 0.09 }, "kind": "list", "text": "THE AUTHORS and FURTHER INTERNATIONAL PHARMA CONTRIBUTORS lists.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "349f2e1e-a23f-4b00-921f-9f4c74aa1fcc", "parentComponentId": null }, { "bbox": { "h": 0.28, "w": 0.39, "x": 0.1, "y": 0.09 }, "kind": "paragraph", "text": "Consumer health: companies focusing on supplying health products and medicines for direct purchase by consumers, e.g. dermatologicals, dietary supplements, OTC medicines, etc. Digital health: companies focusing on the development and supply of digital health solutions, e.g. digital care programs, telemedicine, etc. Generics/biosimilars: companies focusing on the development, manufacturing and marketing of generic active pharmaceutical ingredients. CMOs/CDMOs: companies that serve other pharma companies on a contract basis to provide services from drug development through manufacturing. Diversified – life-sciences-focused: companies that are not specialized in one of the above but offer two or more of the abovementioned segments exclusively within life sciences. Diversified – life sciences and beyond: conglomerates that are not exclusively focused on the pharmaceutical industry and have a significant share of total revenues in other non-life-sciences industries", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a34646b2-2c83-44bb-aa5b-7f0bfa0442df", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.08, "x": 0.04, "y": 0.93 }, "kind": "source-note", "text": "Source: Roland Berger", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "700d0487-912f-488d-8012-dd538992fbb9", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.35, "x": 0.04, "y": 0.39 }, "kind": "title", "text": "M / Methodical approach of Winners Analysis", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7a91a4a3-38a2-43a1-b0a8-4b72f972cf22", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "f183f075-a7cd-4655-bd17-e6196c7dae7f", "evidence": "2x2 grid mapping Growth vs Profit to categorize companies", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 19:04:00.804+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 10, "frameworkName": "matrix-2x2" } ], "arcBeats": [ { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 9, "name": "Impact & Next Steps", "beatId": "271309e4-eb3d-436f-9b66-ea91610673d4", "matchId": "f9d4ffe6-0949-416d-8b21-37386e2bdfe6", "beatType": { "name": "Impact & Next Steps", "slug": "consultants-gambit-impact-next-steps", "status": "active", "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655", "version": 1, "description": null }, "evidence": "The main considerations for pharma executives and appendix provide impact and next steps", "position": 4, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 3, "loop": { "name": "01_logic_chain", "slug": "01-logic-chain", "status": "active", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "canonId": "019dd956-6638-7457-8650-9b0b42e59fb3", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion", "familyLabel": null }, "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0", "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach", "position": 0, "objective": "To demonstrate the logic and reasoning behind the efficiency measures", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:09:04.527992+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 11, "type": "setup", "title": "Standard corporate boilerplate/disclaimer slide.", "function": "summarize", "rawType": "appendix_disclosure", "block": null, "metadata": { "slideType": "appendix_disclosure", "slideTypeCanon": { "name": "Appendix disclosure", "slug": "appendix_disclosure", "status": "active", "canonId": "019de52d-07b2-7549-8e8b-932a19f6e616", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "balanced", "densityScore": 36, "componentCount": 2, "textChars": 830, "nDataPoints": 2, "notes": "Standard corporate boilerplate/disclaimer slide.", "elementsJson": [ "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:03:59.661+00", "seconds": 2.737, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/11", "deck": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99", "deckAnchor": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-11", "deckJson": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json" }, "components": [ { "bbox": { "h": 0.11, "w": 0.17, "x": 0.07, "y": 0.822 }, "kind": "paragraph", "text": "Publisher:\nROLAND BERGER GmbH\nSederanger 1\n80538 Munich\nGermany\n+49 89 9230-0", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.661+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a765e7b9-f3fd-42bb-8482-1e3a3d1818b4", "parentComponentId": null }, { "bbox": { "h": 0.37, "w": 0.58, "x": 0.07, "y": 0.09 }, "kind": "paragraph", "text": "ROLAND BERGER is the only strategy consultancy of European origin with a strong international presence. As an independent firm owned exclusively by our partners, we have 51 offices with a presence in all major markets. Our 3,000 employees are characterized by a unique combination of analytical thinking and an empathetic mindset. Driven by our values of entrepreneurial spirit, excellence, and empathy, we are convinced that business and society need a new, sustainable paradigm that focuses on the whole value-creation cycle. By working in interdisciplinary teams across all relevant sectors and business functions, Roland Berger offers the best expertise worldwide for successfully overcoming the profound challenges of our age now and in the future.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:03:59.661+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d42f7738-6715-4d98-9c59-9ecf74ed1009", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 3, "to": 3, "label": "Situation & Context", "description": "The executive summary provides an overview of the situation and context" }, { "from": 4, "to": 4, "label": "Problem & Complication", "description": "The key takeaways highlight the problems and complications faced by the industry" }, { "from": 5, "to": 6, "label": "Evidence & Proof", "description": "The diagnosis and key takeaways provide evidence and proof of the problems and complications" }, { "from": 7, "to": 8, "label": "Solution & Approach", "description": "The case study and key takeaways provide a solution and approach to addressing the problems and complications" }, { "from": 9, "to": 10, "label": "Impact & Next Steps", "description": "The main considerations for pharma executives and appendix provide impact and next steps" } ], "loops": [ { "from": 3, "to": 10, "label": "Logic Chain", "description": "To demonstrate the logic and reasoning behind the efficiency measures" }, { "from": 4, "to": 9, "label": "Cost Of Inaction", "description": "To highlight the cost of inaction and the importance of efficiency measures" } ] }